Zacks Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-22,729	Closed	-$1.23M	–	742
2025 Q3	$1.23M	Sell	22,729 -31	-0.1%	-$1.77K	0.01%	392
2025 Q2	$1.25M	Sell	22,760 -698	-3%	-$41.1K	0.01%	378
2025 Q1	$1.66M	Buy	23,458 +3,259	+16%	+$219K	0.02%	350
2024 Q4	$1.33M	Buy	20,199 +2,397	+13%	+$161K	0.01%	381
2024 Q3	$1.25M	Sell	17,802 -3,771	-17%	-$315K	0.01%	389
2024 Q2	$1.78M	Buy	21,573 +1,611	+8%	+$134K	0.02%	306
2024 Q1	$1.74M	Buy	+19,962	New	+$1.79M	0.02%	333
2019 Q1	–	Sell	-15,183	Closed	-$1.29M	–	538
2018 Q4	$1.29M	Buy	+15,183	New	+$1.44M	0.03%	302
2016 Q1	–	Sell	-4,188	Closed	-$439K	–	608
2015 Q4	$439K	Sell	4,188 -968	-19%	-$101K	0.01%	439
2015 Q3	$543K	Sell	5,156 -19	-0.4%	-$2.54K	0.02%	413
2015 Q2	$708K	Buy	+5,175	New	+$641K	0.02%	369
2014 Q4	–	Sell	-10,677	Closed	-$770K	–	635
2014 Q3	$770K	Buy	10,677 +274	+3%	+$18K	0.03%	307
2014 Q2	$647K	Buy	+10,403	New	+$628K	0.02%	362